{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:27:54Z","timestamp":1777937274747,"version":"3.51.4"},"reference-count":4,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1177\/1352458519835440","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T10:59:07Z","timestamp":1552906747000},"page":"126-127","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical commentary on \u2018Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis\u2019"],"prefix":"10.1177","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-3350","authenticated-orcid":false,"given":"Stephen W","family":"Reddel","sequence":"first","affiliation":[{"name":"Department of Neurology, Concord Repatriation General Hospital, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"bibr1-1352458519835440","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518813110"},{"key":"bibr2-1352458519835440","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1483330"},{"key":"bibr3-1352458519835440","unstructured":"Coles A, Robertson N, Al-Araji A, et al. Guidance on the prevention of\n                      Listeria\n                      infection after alemtuzumab treatment of multiple sclerosis, 2018, https:\/\/www.theabn.org\/media\/Guidance%20on%20the%20prevention%20of%20Listeria%20infection%20after%20alemtuzumab%20treatment%20of%20multiple%20sclerosis.pdf"},{"key":"bibr4-1352458519835440","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458519835440","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1352458519835440","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458519835440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:58:43Z","timestamp":1777694323000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1352458519835440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1177\/1352458519835440"],"URL":"https:\/\/doi.org\/10.1177\/1352458519835440","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]}}}